Skip to main content

The login for this website is not the same as the login for the main UHMS website (www.uhms.org). If you have not yet registered on this website, please click the Register button below or in the top right corner of the website to create a login for this site.

Your shopping cart is empty
Your Cart is Empty

Please note that this website is a separate website than the UHMS website. Your login credentials for the UHMS website will not work here. If you have not created an account on this website yet, please do so before attempting to log in.

2023 UHMS Chapter Town Hall Meeting hosted by the Midwest Chapter: Wound Care

UHMS Chapter Town Hall Meeting hosted by the Midwest Chapter: Wound Care (Originally presented May 6, 2023) The Midwest Chapter was re-formed to bring together thoughts and issues throughout the multi-state area regarding clinical application to hyperbaric medicine practice. To provide up to date ...Read more
$90.00


  • Course Description
  • Course Credits
UHMS Chapter Town Hall Meeting hosted by the Midwest Chapter: Wound Care

(Originally presented May 6, 2023)

The Midwest Chapter was re-formed to bring together thoughts and issues throughout the multi-state area regarding clinical application to hyperbaric medicine practice. To provide up to date educational offerings, as well as new information related to hyperbaric medicine, and develop a closer relationship with Undersea & Hyperbaric Medical Society.

Wound care products that are safe in HBO2 environment, multiplace vs. monoplace.

Richard Barry, PhD

Larva Therapy

Kyle DuBose, MD

Does Transcutaneous Oximetry remain relevant today?

Dick Clarke, CHT

Frost bite Panel

Laurie Gesell, MD; John Kirby, MD  & David Ajayi, MD

Chamber product safety review: A how to guide

Jace Dower, CHT

Biofilm

Marty Vander Noot, MD


Estimated time to complete this activity: 4 hours

Termination Date: September 6, 2026

Registration cost:

  • Non-Member: $90
  • UHMS Member: Regular: $70
  • UHMS Member: Associate: $50

Meeting Objectives:

  • Discuss the history of larval therapy.
  • Discuss the function of larval therapy.
  • Review the side effects of larval therapy.
  • Review how to order larval therapy.
  • Review the application procedure of larval therapy.
  • Review clinical cases of larval therapy.
  • Summarize screening options in the current era.
  • Describe each respective option’s strengths and weaknesses.
  • Argue that TCOM remains at the heart of the evaluation and case management process.
  • Highlight specific patient selection criteria applicable for the use of hyperbaric oxygen in frostbite.
  • Provide a role for hyperbaric oxygen therapy in a practical approach to hospital management of frostbite.
  • Understand how to determine what items are safe to go into the chamber and the steps behind it.
  • Review why is it always important to make sure which items are going into the chamber.
  • Understand the role of biofilm in chronic wounds.
  • Be able to choose wound care options to reduce biofilm.
CONTINUING EDUCATION

Designation Statements:

  • Physician CME:  The Undersea and Hyperbaric Medical Society designates this enduring material for a maximum of 4.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Nursing CEU:  Approved license types: Advanced Registered Nurse Practitioner; Clinical Nurse Specialist; Licensed Practical Nurse; Registered Nurse; Certified Nursing Assistant; Respiratory Care Practitioner Critical Care; Respiratory Care Practitioner Non-Critical Care; Registered Respiratory Therapist; Certified Respiratory Therapist.  This enduring material is approved for 4.00 contact hours by the Florida Board of Registered Nursing Provider #50-10881.
  • NBDHMT: This enduring material is approved for 2.50 Category A and 1.00 Category B credit hours by National Board of Diving and Hyperbaric Medical Technology, P.O. Box 758, Pelion, South Carolina 29123.
    • NBDHMT Accreditation Statement: For CHT recertification purposes, the NBDHMT requires a minimum of nine of the minimum 12 required Category A credits relate directly to any combination of hyperbaric operations, related technical aspects and chamber safety.

Accreditation Statement: The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Disclaimer: The information provided at this CME activity is for Continuing Medical Education purposes only. The lecture content, statements or opinions expressed however, do not necessarily represent those of the Undersea and Hyperbaric Medical Society.

Full Disclosure Statement: All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with ineligible companies. Full disclosure of faculty and planner relevant financial relationships will be made at the activity. 

Disclosures: All individuals in control of content for this educational activity with their relevant financial relationship disclosed are listed below (if applicable). An individual who refuses to disclose relevant financial relationships will be disqualified from being in control of educational content at any time, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity.

Financial relationships are relevant if the following three conditions are met for the individual who will control content of the education:

  • A financial relationship, in any amount, exists between the person in control of content and an ineligible company.
  • The content of the education is related to the products of an ineligible company with whom the person has a financial relationship.
  • The financial relationship existed during the past 24 months

“None of the individuals in control of content (planners/faculty/reviewers/authors) for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”

There are no relevant financial relationships with ineligible companies to mitigate for this educational activity.

No commercial support was received for this activity.

4.0
4.0
2.5
1.0